Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LIXTE BIOTECHNOLOGY HOLDINGS, INC. | President and CEO, Director | Stock Options | 200K | Nov 6, 2022 | Direct | ||
LIXTE BIOTECHNOLOGY HOLDINGS, INC. | President and CEO, Director | Warrants to Purchase Common Stock | 21.1K | Nov 6, 2022 | By John S. Kovach Trust |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Nov 6, 2022 | 1 | $0 | 4 | Nov 9, 2022 | President and CEO, Director |